// Press Article
Quanta™ Appoints Suresh Persaud Senior Director of Global Manufacturing and Operations
Experienced medical device executive will lead global manufacturing, supply chain, logistics, product quality and demand planning teams
BEVERLY, MASSACHUSETTS – August 8, 2023 – Quanta Dialysis Technologies®, a medical technology company committed to making kidney care more accessible, today announced the appointment of Suresh Persaud as its Senior Director of Global Manufacturing and Operations, effective August 21, 2023. In this newly created role, Mr. Persaud will lead operations encompassing contract manufacturing, supply chain, logistics, product quality, and demand planning. Suresh will be a member of the Quanta Executive Leadership team and report directly to Chief Executive Officer, Alejandro Galindo.
“After a thoughtful and extensive search, we are excited to welcome Suresh Persaud to lead our global manufacturing and operations team,” said Alejandro Galindo, CEO of Quanta. “In addition to his vast experience navigating the highly regulated medical technology industry, Suresh’s proven leadership, focus on operational excellence and commitment to compliance make him a natural fit to the Quanta team. He is a purpose-driven leader who brings an impressive track record of driving results, which will support Quanta’s long-term sustainable growth.”
Mr. Persaud is a global operations executive with more than 25 years of experience leading contract manufacturing and integrated supply chain for multinational companies. Most recently, he served as senior director of integrated business planning at Medtronic, the world-leader in medical technology, services and solutions. He first joined Medtronic as a supply chain manager in 1998, where his many successes led to roles of increasing responsibility and scope.
“I am proud to join Quanta and be part of an organization committed to a purpose- and customer-driven culture,” said Mr. Persaud. “This new challenge will allow me to hone my skills driving efficiencies and improvements across operations and manufacturing systems. I look forward to capitalizing on opportunities to make a positive impact on Quanta’s patients, customers and colleagues.
Mr. Persaud holds a Bachelor of Arts in Business and Enterprise from Edinburgh Napier University.
About Quanta Dialysis Technologies
Quanta Dialysis Technologies is committed to making dialysis accessible to every patient in every setting with its Quanta Dialysis System. As a portable device with performance comparable to larger, traditional machines, the Quanta Dialysis System is a modular and powerful solution that provides the clinical versatility needed to deliver dialysis care across multiple settings. With a simple-to-use and intuitive user interface, it is designed to be operated by a broad range of users to bring dialysis directly to patients.
The Quanta Dialysis System is commercially available in the United Kingdom for home and
hospital use and in the United States, it is FDA-cleared (K222067) for use in chronic and acute
care settings. It is not cleared for home or nocturnal use in the United States.
To learn more about Quanta and its products, visit quantadt.com.
###
Media Contact:
Melinda Freson
Sr Director of Global Marketing, Quanta
press@quantadt.com